- ¿Se reclasificará el cannabis antes del 31 de diciembre?11¢11 %
The DEA administrative process for moving botanical marijuana from Schedule I to Schedule III remains in a limited briefing phase following an October 22 order from Chief ALJ Derek Julius. That ruling admitted a September GAO report highlighting gaps in federal scheduling procedures but denied requests to reopen the June-July 2026 hearings for additional testimony. Optional briefs on the report’s weight are due by November 5, after which the stay lifts and the judge can issue a nonbinding recommendation. An April 2026 Attorney General order already placed state-licensed medical marijuana and FDA-approved products into Schedule III, with the DEA issuing initial federal registrations to over 900 dispensaries in seven states as the first implementation step. Broader rescheduling covering adult-use cannabis requires the full hearing record, agency decision, and potential further review, keeping near-term resolution unlikely.
Reglas
Este mercado se resolverá en "Sí" si la Administración para el Control de Drogas de Estados Unidos (https://www.dea.gov/drug-information/drug-scheduling) reclasifica la marihuana a una categoría inferior a la I (o la excluye completamente de la clasificación) antes del 31 de diciembre de 2026, a las 23:59 ET. De lo contrario, este mercado se resolverá como "No". La principal fuente de resolución de este mercado será la información oficial del Gobierno de EE. UU.; no obstante, también se tendrá en cuenta el consenso de medios de comunicación fiables.
Traducción automática. En caso de disputa, prevalece el original.